Dengue vaccination study
Recruitment for the study is complete: Many thanks to all participants!
Together with renowned vaccine developers, we at the Tropical Institute of the LMU Munich have been researching and working on new developments and improvements of vaccines for almost 20 years.
In our dengue vaccine study, we are testing a novel dengue vaccine (phase II) in a randomized and placebo-controlled manner with regard to its optimal dosage and tolerability.
The recruitment of volunteers for this study has been completed. Many thanks to all participants!
The study in brief
Study objective
Research into the optimal dose and tolerability of a novel dengue vaccine (Phase II)
Study program
A total of 8-9 study dates in 12 months
Participation requirements
- 18-50 years
- in good health
- for women: not pregnant or breastfeeding
- not previously infected with or vaccinated against dengue or Zika
Please note that recruitment for this study has already been completed and no further participants can be accepted.
Allowance for expenses
You will receive appropriate compensation for your participation (€100 per visit + reimbursement of travel expenses if applicable).
